SGP

Supergroup (SGP)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:SGP
DataOraFonteTitoloSimboloCompagnia
01/11/200923:00PR Newswire (US)Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) AnnNYSE:SGP
30/10/200919:12PR Newswire (US)U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant MelanomaNYSE:SGP
30/10/200914:31PR Newswire (US)Critical Alerts for Cisco, Schering-Plough, BHP Billiton, Costco, and American Eagle Released by Seven Summits ResearchNYSE:SGP
29/10/200923:11Dow Jones NewsPriceline.com To Replace Schering-Plough In S&P 500 IndexNYSE:SGPSchering-Plough Corp.
29/10/200922:24Dow Jones NewsUPDATE: US FTC Clears Merck-Schering Deal, With ConditionsNYSE:SGPSchering-Plough Corp.
29/10/200921:43Dow Jones NewsUS FTC Clears Merck-Schering Deal, With ConditionsNYSE:SGPSchering-Plough Corp.
19/10/200914:58Dow Jones NewsJ&J, Schering Arthritis Drug Shows Success In Stopping DamageNYSE:SGPSchering-Plough Corp.
15/10/200914:30PR Newswire (US)Schering-Plough Highlights Boceprevir, Narlaprevir (SCH 900518) and PEGINTRON(R) Data at the American Association for the Study NYSE:SGP
14/10/200906:58Dow Jones NewsAustralian Regulator Oks Schering-Plough Acquisition Of MerckNYSE:SGPSchering-Plough Corp.
08/10/200914:37PR Newswire (US)Intervet/Schering-Plough Animal Health Announces Sponsorship Supporting Milk Producers In MalawiNYSE:SGP
07/10/200917:49Dow Jones NewsDoctors, Drug Executives Say Reform Won't Cure Health Care's IllsNYSE:SGPSchering-Plough Corp.
07/10/200915:31PR Newswire (US)Critical Alerts for Microsoft, Schering-Plough, Yamana Gold, Whole Foods, and Chalco Released by Seven Summits ResearchNYSE:SGP
06/10/200921:17Dow Jones NewsSchering CEO Warns Of Loss Of Innovation In Drug Cos' DealsNYSE:SGPSchering-Plough Corp.
05/10/200919:49Dow Jones NewsUPDATE: FDA Panel Narrowly Backs Schering's Pegintron For MelanomaNYSE:SGPSchering-Plough Corp.
05/10/200918:16Dow Jones NewsFDA Panel Narrowly Backs Schering's Pegintron For MelanomaNYSE:SGPSchering-Plough Corp.
28/09/200915:01Dow Jones NewsMerck To Sell CSL's Flu Vaccine In US Starting Next YearNYSE:SGPSchering-Plough Corp.
23/09/200920:43Dow Jones NewsSchering's Hassan Stresses Innovation In Success For PharmaNYSE:SGPSchering-Plough Corp.
22/09/200900:39Dow Jones NewsBoehringer Ingelheim To Acquire Wyeth's Animal Health AssetsNYSE:SGPSchering-Plough Corp.
14/09/200923:02Dow Jones NewsSchering, Merck Spent $60 Million On Medical Education For DoctorsNYSE:SGPSchering-Plough Corp.
11/09/200900:34Dow Jones NewsJ&J's Centocor Unit Gets FDA Response Letter On DoxilNYSE:SGPSchering-Plough Corp.
03/09/200910:31Dow Jones NewsCORRECT: Dainippon Sumitomo In Talks To Buy SepracorNYSE:SGPSchering-Plough Corp.
03/09/200906:39Dow Jones News2nd UPDATE: Dainippon Sumitomo In Talks To Buy SepracorNYSE:SGPSchering-Plough Corp.
03/09/200905:10Dow Jones NewsUPDATE: Dainippon Sumitomo In Talks To By SepracorNYSE:SGPSchering-Plough Corp.
01/09/200901:13Dow Jones NewsUPDATE: US Court Denies Schering-Plough $473 Million Tax RefundNYSE:SGPSchering-Plough Corp.
01/09/200900:28Dow Jones NewsUS Court Denies Schering-Plough $473 Million Tax RefundNYSE:SGPSchering-Plough Corp.
31/08/200919:59Dow Jones NewsUPDATE: Merck Names New Management Team For Combined CoNYSE:SGPSchering-Plough Corp.
31/08/200915:44Dow Jones NewsMerck Names New Management Team For Combined Co.NYSE:SGPSchering-Plough Corp.
30/08/200914:27Dow Jones NewsSanofi-Aventis Reports Phase II Trial Success For OtamixibanNYSE:SGPSchering-Plough Corp.
14/08/200917:29Dow Jones NewsSUBSCRIBERS: FDA OKs Saphris News Already ReportedNYSE:SGPSchering-Plough Corp.
14/08/200914:00Dow Jones NewsFDA OKs Schering-Plough Drug For Schizophrenia, BipolarNYSE:SGPSchering-Plough Corp.
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:SGP

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network